Cargando…
Serial MRI studies over 12 months using manual and atlas-based region of interest in patients with amyotrophic lateral sclerosis
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by loss of upper and lower motor neurons. There is a need for an imaging biomarker to track disease progression. Previously, magnetic resonance imaging (MRI) has shown loss of grey and white matter in the br...
Autores principales: | Alruwaili, Ashwag R., Pannek, Kerstin, Henderson, Robert D., Gray, Marcus, Kurniawan, Nyoman D., McCombe, Pamela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397614/ https://www.ncbi.nlm.nih.gov/pubmed/32746800 http://dx.doi.org/10.1186/s12880-020-00489-w |
Ejemplares similares
-
Tract integrity in amyotrophic lateral sclerosis: 6–month evaluation using MR diffusion tensor imaging
por: Alruwaili, Ashwag R., et al.
Publicado: (2019) -
Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis
por: Devine, Matthew S., et al.
Publicado: (2015) -
The Peripheral Immune System and Amyotrophic Lateral Sclerosis
por: McCombe, Pamela A., et al.
Publicado: (2020) -
Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
por: Xu, Zhouwei, et al.
Publicado: (2016) -
Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions
por: Ngo, Shyuan T, et al.
Publicado: (2017)